Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STIM2 antisense RNA 1 (STIM2-AS1) is a long non-coding RNA (lncRNA) transcribed in the antisense direction relative to the STIM2 gene. It is not a protein, enzyme, receptor, ion channel, or other canonical drug target, but instead belongs to the class of non-coding RNAs which may have regulatory functions at the transcriptional or post-transcriptional level. Currently, there are no definitive published data describing its specific molecular function, interacting proteins, involvement in disease, or potential as a therapeutic target. It is important to note that many references to "STIM2" in the literature refer specifically to the stromal interaction molecule 2 protein, not to the STIM2-AS1 lncRNA. If you are seeking information on a drug target, note that STIM2-AS1 is not a recognized therapeutic target. The canonical drug target is stromal interaction molecule 2 (STIM2), a calcium sensor and protein, not STIM2-AS1. Most published functional and disease data relate to the protein and not to the antisense RNA. Notes: - The search results provided do not reference STIM2-AS1, and all detailed published findings discuss "STIM2" as a protein involved in calcium signaling (a known drug target), not the antisense RNA[1][2][3][4][5]. - If you meant "STIM2" (stromal interaction molecule 2), please clarify; otherwise, STIM2-AS1, as an lncRNA, should not be classified as a canonical drug target. Summary: STIM2 antisense RNA 1 (STIM2-AS1) is a non-coding transcript with unclear biological functions and no established role as a therapeutic target. Most literature refers to the protein STIM2, not to the antisense RNA. If information on a drug target is required, review "STIM2" (stromal interaction molecule 2) rather than STIM2-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on STIM2 antisense RNA 1 (STIM2-AS1).